Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

PAD patients face greater risk of death, complications after a heart attack
PAD and CLI patients who show signs of coronary heart disease may benefit from early treatment, according to a new study of nearly 4 million hospitalizations.
SCAI 2024 Scientific Sessions to focus on TAVR, PAD and other key trends in interventional cardiology
Interventional cardiologists from all over the world will gather for three days of educational sessions, late-breaking presentations, live cases and more. The festivities begin Thursday, May 2, in Long Beach, California.
Cardiologist details the many health disparities he encounters in rural Mississippi
Foluso Fakorede, MD, an interventional cardiologist with Cardiovascular Solutions of Central Mississippi, says these issues are typically overlooked in today's healthcare environment.
FDA approves Abbott’s resorbable stent for BTK arteries
The bioresorbable stent, examined at length for the LIFE-BTK clinical trial, stays in place for up to three years before completely dissolving.
FDA clears new catheter for peripheral blood clots
The new-look catheter came out of a medical device incubator started by entrepreneur Eitan Konstantino, PhD, who has years of experience in the vascular space.

With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.

No antithrombotic therapy after TAVR? New research highlights potential benefits

The study, published in JACC: Cardiovascular Interventions, focused on data from more than 3,500 TAVR patients.

December 19, 2022

Corindus, acquired back in 2019, is now Siemens Healthineers Endovascular Robotics

The company's most well-known product within the industry is the CorPath GRX System, a second-generation robotics solution used by interventional cardiologists during PCI and other interventional procedures.

December 15, 2022

Treatments for rheumatoid arthritis, Parkinson’s disease linked to cardiovascular benefits

New research published in Annals of Rheumatic Diseases and Hypertension examined the impact medications for different non-cardiovascular conditions can have on a patient's heart health.

December 9, 2022

Seaweed molecules could lead to big improvements for heart surgery patients

“There is a crucial need to develop synthetic vascular graft materials that will increase the rate of long-term functions,” one researcher said. Could materials derived from seaweed help fill that need?

December 5, 2022

doctor fruits vegetables vegetarian diet. Embracing a plant-based diet can improve a person’s cardiovascular health, according to a new commentary published in the American Journal of Cardiology.[1] The article, titled “Are We What We Eat? The Moral Imperative of the Medical Profession to Promote Plant-Based Nutrition,” also highlights multiple reasons that choosing plant-based nutrition over animal-based food can be viewed as being better for society as a whole.

Cardiologist urges physicians to promote plant-based diets: ‘We owe it to the profession, our patients and the planet’

The authors of a new commentary in the American Journal of Cardiology argued that well-balanced plant-based diets are good for the heart and good for society as a whole.

December 1, 2022

Chest X-ray. Using an explainable artificial intelligence (AI) model, researchers were recently able to accomplish highly accurate labeling on large datasets of publicly available chest radiograph X-rays..

New AI model calculates risk of heart attack or stroke using a single X-ray

“This type of screening could be used to identify individuals who would benefit from statin medication but are currently untreated," one specialist said. The full analysis will be presented at RSNA 2022 in Chicago.

November 28, 2022

FDA approves world’s most expensive drug, a hemophilia B treatment expected to cost $3.5M

The single-dose gene therapy can help patients reduce their risk of bleeding events and discontinue factor IX prophylaxis therapy.

November 23, 2022

Interview with the late-breaking BEST-CLI trial principal investigators Alik Farber from Boston Medical Center, Matthew Menard from Brigham and Women's Hospital, and Ken Rosenfield at Mass General Hospital, at the 2022 American Heart Association (AHA) meeting. The trial looked at endovascular versus bypass surgery in patients with critical limb ischemia (CLI) to see which is better. #AHA22

VIDEO: Surgery vs. endovascular intervention for critical limb ischemia in the BEST-CLI trial

Watch our exclusive interview, recorded live at the AHA Scientific Sessions 2022 conference, with three investigators from the BEST-CLI trial.

November 21, 2022

Vascular & Endovascular

PAD patients face greater risk of death, complications after a heart attack

SCAI 2024 Scientific Sessions to focus on TAVR, PAD and other key trends in interventional cardiology

Cardiologist details the many health disparities he encounters in rural Mississippi

FDA approves Abbott’s resorbable stent for BTK arteries

FDA clears new catheter for peripheral blood clots